The global safety syringes market, valued at approximately USD 7.1 billion in 2022, is projected to grow at a steady compound annual growth rate (CAGR) of over 4.5% during the forecast period from ...

Faced with soaring prices and limited access to obesity medications, a growing number of Americans are taking matters into ...

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...

Biocon Biologics secures Health Canada approval for Yesafili, the first biosimilar to Eylea® in Canada, with a global launch ...

Kolkata: Endocrinology professor at SSKM Sujoy Ghosh's innovative model for detection and treatment of paediatric diabetes in ...

An expert committee that advises the Centers for Disease Control and Prevention on vaccines is meeting for the first time since Health Secretary Robert F. Kennedy Jr. abruptly replaced the committee's ...

The global Insulin Delivery Device Market, valued at US$32.6 billion in 2024 stood at US$35.3 billion in 2025 and is ...

Wegovy is being made available in five dosing strengths with an easy-to-use pen device, which does away the use of syringes ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...

Type 1 diabetes concept suggested by insulin syringe] adrian825 Vertex Pharmaceuticals (NASDAQ:VRTX [ has posted new data from a Phase 1/2/3 study for zimislecel (VX-880), its experimental therapy for ...

The Diabetes Devices Market was valued at US$ 33.4 Billion in 2024 and is projected to reach US$ 64.8 Billion by 2033, growing at a CAGR of 7.7%. The U.S. diabetes devices market is witnessing strong ...